https://pittplusme.org/study/lifestylechange
GLP-1 Medications and Healthy Nutrition/Physical Activity Programs
STUDY BASICS
Are you taking a GLP-1 medication? You may be eligible for a research study focused on how patients being prescribed or taking GLP-1 medications learn about, and participate in, structured programs that improve or maintain healthy nutrition or physical activity. Participation includes a brief survey and, for some participants, a follow-up interview.
STUDY PURPOSE
The purpose of this research study is to understand how patients being prescribed GLP-1 medications think about and participate in programs that improve or maintain healthy nutrition or physical activity.
COULD THIS STUDY BE RIGHT FOR YOU?
- Are 18 or older
- Are not currently pregnant
- Taking a GLP-1 medication such as:
- Semaglutide (e.g. Ozempic® or Wegovy®)
- Tirzepatide (e.g. Mounjaro® or Zepbound®)
- Liraglutide (e.g. Victoza®)
- Dulaglutide (e.g. Trulicity®)
- and others
WHAT PARTICIPANTS CAN EXPECT
You will get a link to an online survey that will take about 15 minutes to complete. Additionally, if you volunteer, you may be invited to a virtual follow-up interview.
IRB: STUDY25100204
- Understanding lifestyle change intervention implementation in clinicians and providers
MEET THE RESEARCHER
Shari Rogal
Shari Rogal, MD, MPH, is an Associate Professor in the Departments of Medicine and Surgery at the University of Pittsburgh, Co-Director of the IMPACT and Implementation Lab Cores at Pitt’s Clinical and Translational Science Institute, and a Core Investigator and staff transplant hepatologist at the VA Pittsburgh Healthcare System. A Pittsburgh native, Dr. Rogal’s research interests include liver transplant outcomes with a particular focus on addiction and pain in chronic liver disease patients. She is also interested in using implementation science to address health disparities.